FG-3246

· Kyntra Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FG-3246, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [Phase 2]